Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbin Pharmaceutical Group Sanjing Heihe Pharmaceutical is a subsidiary of the Harbin Pharmaceutical Group (Hayao), one of China's largest state-owned pharmaceutical conglomerates. Based in Heihe, Heilongjiang, the company specializes in the production, wholesale, and distribution of a wide range of pharmaceutical products, including traditional Chinese medicines, chemical drug preparations, and health supplements. It operates under the prestigious "Sanjing" brand, which is highly recognized in the Chinese market for its over-the-counter (OTC) oral liquids and nutritional products. The company plays a vital role in the regional supply chain, leveraging the parent group's extensive manufacturing capabilities and R&D resources. Its business focus remains on providing accessible healthcare solutions through a robust portfolio of essential medicines and wellness products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbin Pharmaceutical Group Sanjing Heihe Pharmaceutical.